Profile subject Cédric Blanpain describes his work rooting out the role of stem cells in tumors.
By Megan Scudellari | July 1, 2013
Read the full story.
Sign In with your LabX Media Group Passport to leave a comment
Not a member? Register Now!
By Kate Yandell
Mice engineered to have just one copy of the gene Myc live longer, healthier lives than wild-type animals.
By Kerry Grens
The pharmaceutical company bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.
By Anna Azvolinsky
An analysis of 31 tissues finds that random mutations acquired during stem cell divisions correlate with lifetime cancer risk—more so than heritable mutations and environmental factors combined.
View the January 2015 contents.
© 1986-2015 The Scientist